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Abstract 
The main aim of this study was to employ high-resolution magnetic resonance imaging 
(MRI) to investigate the spatiotemporal development of pathological features associated with 
contusive spinal cord injury (SCI) in mice. Experimental mice were subjected to either sham 
surgery or moderate contusive SCI. A 16.4T small animal MR system was then employed for 
non-destructive imaging of post-mortem, fixed spinal cord specimens at the sub-acute (7 
days) and more chronic stages (28-35 days) post-injury. Routine histological techniques were 
used for subsequent investigation of the observed neuropathology at the microscopic level. 
The central core of the lesion appeared as a dark hypo-intense area on MR images at all time 
points investigated. Interestingly, small focal hypo-intense spots were observed spreading 
through the dorsal funiculi proximal and distal to site of impact, particularly in those areas 
known to be undergoing gliosis and Wallerian degeneration. Histological examination 
revealed these hypo-intense spots to be high in iron content as determined by Prussian blue 
staining. Quantitative image analysis confirmed the increased presence of iron deposits at all 
post-injury time points investigated (p<0.05). Distant iron deposits were also detected via live 
imaging without the use of contrast-enhancing agents, enabling longitudinal investigation of 
this pathology in individual animals. Further immunohistochemical evaluation showed that 
intracellular iron co-localised to macrophages/microglia, astrocytes and oligodendrocytes in 
the sub-acute phase of SCI but predominantly GFAP+CC-1+ astrocytes at later stages of 
recovery. Thus, progressive, widespread intraspinal iron accumulation is a feature of SCI in 
mice and high-resolution MRI can be effectively used as a diagnostic tool to monitor these 
neuropathological changes with time.  
 
Keywords: 
Neurotrauma, secondary injury, astrogliosis, neural scar, neurodegeneration, haemorrhage  
Highlights: 
We used an ultra-high field (16.4T) MR system to image the lesioned mouse spinal 
cord.We then correlated abnormal features in MR images with microscopic 
histopathology.We show that hypo-intense MR features result from abnormal iron 
accumulation.Ultra-high field MRI was able to resolve this pathology at the single cell 
level.Intracellular iron stores could be visualised ex vivo as well as in vivo. 
 
1. Introduction: 
Spinal cord injuries (SCIs) typically involve a crush or bruising of the spinal cord as a result 
of fracture and/or dislocation of the spine, with most human cases classified as anatomically 
incomplete, contusive injuries (Bunge et al., 1993; Norenberg et al., 2004). Patients suffering 
SCI often experience symptoms that may include paralysis, loss of sensation and autonomic 
dysfunction at and below the level of injury (McDonald and Sadowsky, 2002); these 
disabilities are normally permanent because of the very limited inherent capacity of the 
mammalian central nervous system (CNS) to repair itself. The exact nature and severity of 
neurological impairments are heavily influenced by both the size and level of the injury 
(Ghasemlou et al., 2005; Lucin et al., 2007; Davis and Steward, 2010). 
 
The initial mechanical damage inflicted on the spinal cord at the time of injury is traditionally 
defined as the ‘primary injury’. This event triggers a complex series of pathophysiological 
cellular and molecular events in which oxidative stress, excitotoxicity and immune activation 
exacerbate the consequences of the primary injury by spreading the damage into the 
neighbouring neural tissue that was originally spared; these injurious cascades are 
collectively referred to as ‘secondary damage’ (for reviews, see Schwab and Bartholdi, 1996; 
Juurlink and Paterson, 1998; McDonald and Sadowsky, 2002). The ultimate appearance of 
the lesion site and associated neurological deficits are thus the resultant of both the primary 
and secondary injury.  
 
Magnetic resonance imaging (MRI) is the most commonly used imaging modality to 
diagnose and study SCI in humans (Do-Dai et al., 2010; Cohen-Adad et al., 2011). The 
continuous improvements in MRI technology, including increasing magnetic field strengths, 
has increased resolution and improved soft tissue contrast, making it particularly well suited 
to distinguish grey and white matter regions, and to detect subtle pathological changes in 
tissue structure and integrity within the lesioned spinal cord. High field MRI also enhances 
the detection of susceptibility effects from iron beyond the actual physical size of the deposit. 
With a number of putative therapeutics currently being tested for clinical use (for review, see 
Gensel et al., 2011), there is an urgent need to further develop and optimise non-invasive 
imaging methods to better study and characterise pathology in translational animal models of 
SCI.  
 
The common pathology associated with human SCI can be accurately mimicked in rodent 
models of contusive injury (e.g. Scheff et al., 2004), and several studies have already utilised 
MRI to investigate lesion sites both in vivo and ex vivo albeit at inferior resolution (e.g. Nishi 
et al., 2007; Gonzalez-Lara et al., 2009; Gonzalez-Lara et al., 2010; Herrera et al., 2010; 
Byrnes et al., 2010; Gonzalez-Lara et al., 2011). The application of MRI to pre-clinical, 
animal-based SCI research offers several advantages, perhaps of greatest importance being 
the fact that MR imaging ultimately allows for longitudinal studies on lesion site 
development within live animals and direct translation to human trials because of its non-
invasive nature. The development of more clinically relevant assessment methods to 
investigate important outcome parameters such as lesion volume, white matter sparing and 
treatment effects should ultimately aid the successful translation of putative therapeutics from 
bench-to-bedside.  
 
The main aims of this study were to employ high-resolution MRI to investigate abnormal 
features associated with contusive SCI at unsurpassed resolution in both post-mortem tissue 
samples as well as live mice using a 16.4T small animal MRI, and to correlate abnormalities 
with microscopic pathology in tissue sections using conventional histological techniques and 
immunostaining procedures. We demonstrate that ultra-high field MRI can be used to study 
the injured rodent spinal cord in great detail with no detectable loss of tissue antigenicity. 
Specifically, we report widespread iron accumulation not only within the lesion core but also 
more distant areas, particularly within the dorsal funiculus of the spinal cord, as part of 
normal SCI pathology. These trends could be observed both ex vivo and with live imaging. 
Histological analysis confirmed the presence of small iron deposits outside the lesion core 
area, further revealing that these were mostly confined to reactive astrocytes. The established 
baseline data demonstrate the power of ultra-high field MRI as a diagnostic tool to detect 
pathological features at single cell resolution in SCI research.  
 
 
 
 
2. Materials and methods: 
 
2.1 Animals 
Female C57BL6/J mice, 10-16 weeks of age, were housed under conventional conditions 
with a 12 hour light-dark cycle and free access to food and water. All experiments were 
approved by the The University of Queensland animal ethics committee and conducted in 
accordance with the policies established by the National Health and Medical Research 
Council (NHMRC), Australia. Mice were randomly allocated into the following groups: (1) 
SHAM-operated animals, i.e. “laminectomy only” (n=3), (2) 7 days post-SCI (n=4) and (3) 
28-35 days post-SCI (n=5). After establishing MRI methodology ex vivo, longitudinal live 
imaging was conducted at day 0, 14 and 35 post-SCI (n=2). Of note, Cx3cr1+/gfp mice were 
utilized (n=8 evenly spread over the groups) to aid the visualisation of activated microglia 
and blood borne macrophages at the injury site. In these mice, the coding sequence for 
enhanced green fluorescent protein (eGFP) was inserted into the Cx3cr1 coding region, which 
places eGFP expression under Cx3cr1 promoter control in the targeted allele  (Jung et al., 
2000).  
 
2.2 Experimental spinal cord injury  
Mice were anaesthetized with a mix of ketamine (10 mg/kg) and xylazil (20 mg/kg), 
following which a dorsal incision was made along the midline of the lower thoracic region. 
Next, the underlying paravertebral muscles were carefully split and dorsal laminectomy 
performed at the level of the thoracic (T) vertebra T9 to expose the underlying spinal cord. 
The vertebral column was then stabilized via rostral and caudal placement of Addson 
microforceps clamps, after which the mice were subjected to a moderate (50kdyne) force-
controlled spinal contusion injury using the Infinite Horizon Impactor (Precision Systems and 
Instrumentation, LLC). Following the impact, the muscles were stitched back together and 
the overlying skin sutured with Michel wound clips and/or VetbondTM (3M Animal Care 
Products). Immediately after surgery, experimental mice received a single dose of 
buprenorphine (0.05 mg/kg), diluted in 1 ml of Hartmann’s solution, in addition to 
administration of gentamycin (1 mg/kg) once daily for 5 days post-surgery. Bladders were 
voided manually twice daily for the duration of the experiment if required or until the return 
of the micturition reflex, whichever occurred first. 
 
2.3 Tissue preparation for post-mortem imaging 
Experimental mice were deeply anaesthetised with Lethabarb (150 mg/kg; Virbac, Australia) 
at the designated time point of 7 or 28-35 days post-SCI. Mice were then transcardially 
perfused with 20ml of heparinized saline (0.9% NaCl), followed by 30 ml of 4% 
paraformaldehyde (PFA) in phosphate-buffered saline (PBS: 1.7 mM NaH2PO4, 9 mM 
Na2HPO4, 0.15M NaCl, pH 7.4). The vertebral column was then dissected and post-fixed 
overnight at 4°C. After extensive washing in PBS, fixed specimens were subsequently 
incubated in PBS containing 0.2% (v/v) of the contrast-enhancing agent Magnevist® (Bayer, 
Australia) for >24 hours pre-imaging.  
 
2.4 Post-mortem magnetic resonance (MR) imaging 
All MRI data was acquired at the Centre for Advanced Imaging (The University of 
Queensland) using a 16.4T vertical wide-bore NMR spectrometer, interfaced with Advance II 
electronics, running Paravision 5.0 software (Bruker BioSpin, Germany) Fixed specimens of 
the lower thoracic vertebral column and spinal cord were trimmed such that they fitted tightly 
into a 1.0 cm glass tube whilst still immersed in Magnevist/PBS solution. The tube was then 
placed inside a quadrature birdcage coil with an inner diameter of 10 mm (M2M Imaging 
Inc., USA). T1/T2*-weighted images were acquired using a 3D gradient echo FLASH 
sequence (Fast Low Angle Shot; Haase et al., 1986). Gradient-echo sequence was chosen as 
the preferred MRI acquisition sequence because it can produce ultra-high resolution images 
with greater signal-to-noise per unit time. Furthermore, at high magnetic field, the gradient 
echo sequence is also highly sensitive to local magnetic-field inhomogeneity such as small 
paramagnetic iron deposits in tissues. Specific imaging parameters were as follows: 
TR/TE=40/6.5 ms, flip angle = Ernst angle ~ 25°, field-of-view = 8X28X8 mm, acquisition 
matrix 400X1024X400, image resolution 20X27X20 µm, averages = 4, acquisition time = 12 
hrs 40 min. These imaging parameters were settled upon after pilot studies revealed that 
shorter ‘Echo Times’ (TEs) provided clear visualization of the hypointense regions of the 
injured spinal cord while still maintaining adequate contrast between grey and white matter 
(Fig. 1). MR images were viewed and processed using OsiriX imaging software (Pixmeo 
SARL, Geneva, Switzerland; Rosset et al., 2004).  
 
2.5 Tissue processing for histological analysis 
Following the conclusion of post-mortem MR imaging, the spinal cords were dissected out 
from the vertebral columns and washed extensively in PBS. Next, the tissue was 
cryoprotected via subsequent overnight incubations in PBS containing 10% and 30% sucrose, 
respectively. Spinal cords were then snap-frozen in dry ice-cooled iso-pentane and stored at -
80oC until further processing. Tissue sections (16µm) were cut on a Leica cryostat and 
collected in 1:5 series on Superfrost Plus slides (Menzel, Germany). Slides were air-dried for 
2 hours and then stored at -80oC until further processing. 
  
 
 
2.6 Prussian Blue staining and immunohistochemical staining procedures 
Standard Prussian blue staining was used to visualise iron accumulation within the tissue. In 
brief, slides were allowed to air dry before being washed in distilled water for 3 x 5 min. 
Slides were then incubated in 10% ferrocyanide solution (w/v; Sigma) for 10 min at room 
temperature (RT), followed by a 15 min incubation in 5% ferrocyanide (w/v) + 5% HCl 
solution (v/v). After development of the staining, slides were washed for 3 x 5 min with 
distilled water. Slides were then dehydrated in gradients of ethanol and cleared with xylene 
before being coversliped with DPX mounting medium (Merck Pty. Ltd., Australia). 
When combined with immunohistochemistry, slides were washed 3 x 5 min in PBS 
following the conclusion of Prussian blue staining (as detailed above), followed by quenching 
of endogenous peroxidise activity with 0.3% H2O2 in 100% methanol for 20 min. After 
another round of washings, slides were immersed in blocking solution containing 2% Bovine 
Serum Albumin (BSA; Sigma) and 0.2% Triton X-100 (Sigma) in PBS for 1 hour to reduce 
non-specific antibody binding. BEATTM blocker kit (Invitrogen) was employed according to 
manufacturer’s instructions where appropriate to allow for the use of mouse primary 
antibodies on mouse tissue. The sections were incubated overnight in a humidified chamber 
at 4oC with either primary rabbit anti-GFP antibody (1:800; Millipore), rabbit anti-GFAP 
(1:1000; DakoCytomation) or mouse anti-CC1 (1:500; Abcam). The following day, slides 
were washed extensively for 3 x 10 min in PBS and incubated with the appropriate secondary 
antibody, i.e. biotinylated goat anti-rabbit or horse anti-mouse antibody (1:200; Vector 
Laboratories) for 1.5 hours at RT. After another round of washings to remove unbound 
antibody, slides were incubated with ABC reagent (1:200; Vector laboratories) for 1 hour at 
RT. The staining was developed after a final round of washings by incubating the slides for 
approximately 6 min with either 3, 3-diaminobenzidine (DAB; Sigma) or 3-amino-9-
ethylcarbazole (EAC; Sigma), resulting in a brown or red precipitate, respectively. The 
reaction was stopped via immersion of the slides in ddH2O, after which they were dehydrated 
through graded series of ethanol (DAB staining) and coverlipped in DPX mounting medium. 
For AEC staining, sections were covered with ImmunoHistoMount (Sigma) and air dried for 
approximately one day before being coverslipped in DPX mounting medium. 
 
2.7 Quantification of Prussian blue staining 
Prussian blue stained tissue sections were scanned on an Aperio scanscope system using the 
20x objective. For each animal, three sections, both rostral and caudal from the injury site, 
covering ~3-5 mm in each direction, were randomly chosen for iron quantification. Matching 
sections were selected from SHAM-operated control animals. The relative area of the section 
covered by Prussian blue staining was calculated in ImageJ by dividing the positively stained, 
i.e. iron-containing areas by the total area of each section. Since no differences were observed 
between measures taken from proximal or distal segments of the spinal cord, the percentage 
area obtained for each section was averaged for each animal (i.e. 6 sections in total per 
animal). 
 
2.8 In vivo MR imaging 
In vivo MR imaging was performed to determine if iron accumulation could be detected 
within the injured spinal cord of live mice. For this, mice were anaesthetized using 1.5-2% 
isoflurane and oxygen as a diluent (1 L/min). A 1.5x3 cm transmit/receive linear surface coil 
(M2M Imaging) was placed dorsally over the injured area of the spinal cord. Breathing was 
monitored throughout the duration of imaging using BIOTRIG (SpinSystems, Australia) and 
maintained around 40 breaths per minute by adjusting the isoflurane level and oxygen flow 
rate as appropriate. Respiratory gating was employed to reduce movement artifacts. Gradient 
echo 2D images were acquired using the following parameters: TR = 350ms, TE = 2.83 ms, 
flip angle=40o, slice thickness = 250 µm, number of slices = 11, field-of-view = 40X10mm, 
matrix = 320X128, image resolution 125X78 µm, averages = 12, acquisition time = 7.5 min. 
Spin echo based RARE images were also acquired with the same geometry and the following 
parameters, TE = 14 ms, RARE factor = 4, TR = 1000, averages = 12, acquisition time = 6.5 
min.   
 
2.9 Statistical analysis 
Obtained datasets were analyzed for differences in levels of intra-spinal iron using one-way 
ANOVA and Newman-Keuls post-hoc test. Data sets were considered to be significantly 
different from each other if a p-value of less than 0.05 was obtained.  
3. Results: 
 
3.1 Hypo-intense regions are a pathological feature in T1/T2* MR images of the injured 
mouse spinal cord  
Post-mortem, high-resolution MRI was conducted using a 16.4T small animal MRI in the 
sub-acute and more chronic stages of spinal cord injury, i.e. 7 and 28-35 days post-injury, 
respectively, as well as for sham-operated mice. In all MR images of the injured spinal cord 
with scar development, the central core of the lesion appeared as a dark hypo-intense area 
(Fig. 2A, C). Discrete points of loss of MR signal were also apperent further away from the 
lesion site, mostly along the dorsal funiculi (arrows in A and C). This loss of signal was very 
prominent at 7 days post-injury both proximal and caudal to the injury site (Fig. 2A), where it 
was detected for at least up to 3.5 ± 0.5mm and 4.8 ± 1.0mm, respectively. Signal loss along 
the dorsal columns was still apparent as time progressed to the more cronic stages (Fig. 2C), 
both rostrally (4.1 ± 1.1mm) as well as caudally (2.5 ± 0.8mm) from the lesion epicentre. 
SHAM-operated animals did not show any such hypo-intense regions within the spinal cord 
(Fig. 2D).  
 
3.2. Prussian Blue staining correlates MRI hypointense regions with iron deposition 
MR images were next compared to Prussian blue stains of the same specimens in order to 
determine whether the loss of MR signal following SCI resulted from iron accumulation. 
Prussian blue staining revealed a uniform and diffuse iron presence throughout the lesion 
core (Fig. 2B). A more distinct and scattered  iron staining pattern, which appeared to be 
intracellular, was present in the grey and white matter areas surrounding the lesion core. 
Further distal and proximal to the lesion site, Prussian blue staining was mostly localised to 
the dorsal column area, in a fashion that appeared to largely overlap with the observed 
distribution of hypo-intense regions in MR images. Coronal sectioning confirmed the 
presence of Prussian blue+ cell-shaped structures in the dorsal column area, both proximal 
(Fig. 2E) and distal (Fig. 2F) to the lesion core of experimental mice at 28-35 days post-SCI. 
Iron accumulation was evident in tissue sections for at least 5 millimetres proximal and distal 
to the lesion site, i.e. the furthest point investigated. Quantitative analysis of Prussian blue 
content in these areas revealed significantly higher (p<0.05) iron accumulation rostral and 
caudal to the lesion site at both 7 and 28-35 days post-injury in comparison to sham-operated 
mice (Fig. 2G). 
 
3.3 Iron accumulation following SCI is mostly confined to the lesion epicentre and reactive 
astrocytes  
Double immunohistochemical staining procedures with glial- and macrophage-specific 
antibodies were used to further examine the distribution pattern of Prussian blue staining that 
was observed in the injured spinal cord relative to hypo-intense areas within MR images. 
Examination of a higher power cross-sectional post-mortem MR image at 28 days post-injury 
again showed the lesion epicentre as a black, hypo-intense region with well defined lesion 
borders in addition to several other hypo-intense clusters at the lesion margins (Fig. 3A), 
while hyper-intense regions in the spared white matter around the central lesion core 
represent demyelinated areas (Cowin et al., 2011). A transverse histology section of the same 
specimen and at  approximately the same location revealed a remarkable overlap between the 
hypo-intense regions in the MR image and Prussian blue stained regions (Fig. 3B). A more 
diffuse pattern of Prussian blue staining was present throughout the lesion core, most likely 
associated with deposition of extracellular matrix within the neural scar. More distinct iron 
deposits were found scattered around the lesion margins as well as in proximal and distal 
direction. These deposits appeared to be intracellular based on their morphological 
appearance. We used Cx3cr1gfp mice on the assumption for this iron staining to be most likely 
present inside phagocytic macrophages, potentially as a result of coagulated blood clearance 
and associated debris from the injury site. However, little overlap was observed between 
GFP-stained macrophages and Prussion blue staining. Most of the activated microglia and/or 
macrophages in the injured spinal cord did not show any intracellular iron deposits and the 
few double-positive cells that were observed were mostly present at at the lesion margin (Fig. 
3C, D). Additional double staining on adjacent sections revealed that most of this 
accumulated iron was present inside GFAP+ astrocytes at the 28-35 day time point (Fig. 3E). 
Further examination of iron accumulation at the earlier time point, i.e. 7 days post-SCI, 
revealed again that most of this had accumulated inside GFAP+ astrocytes (Fig. 4A-C) 
although slightly more Prussian blue+ macrophages/microglia (Fig. 4D-E) were qualitatively 
observed at this early timepoint. As oligodendrocyes in the injured spinal cord are also 
known to contain  high levels of iron (Schonberg and McTigue, 2009), we conducted 
additional stainings using CC-1 as a marker for mature oligodendrocytes. Indeed, CC-1+ cells 
with typical oligodendrocyte morphology and intracellular iron stores could be detected 
around the lesion center as well as more proximal and distal to it at the early 7 day time point 
(Fig. 4G-I).  
 
 
3.4 Visualising iron accumulation within the injured spinal cord of live mice 
We next sought to ascertain that the above detailed MR features associated with SCI 
pathology could also be detected through live-imaging with much shorter imaging times and 
without pre-treatment with Magnevist® for contrast enhancement. For in vivo MRI, we made 
use of the 3D gradient-echo imaging protocol that was developed for post-mortem tissue 
samples, with the parameters being adjusted for 2D image acquisition to shorten sampling 
time, a longer TR to compensate for the absence of Magnevist contrast agent, and a shorter 
TE to minimize imaging artifacts from bone. Spin echo images of the same sample were also 
collected. Regardless of acquisition method, the lesion core already shows up as a dark hypo-
intense region immediately after SCI ( i.e. 4 hours post-injury; Fig. 5A), which is most likely 
the result of microhaemorrhaging caused upon impact by the actual contusion injury of the 
spinal cord. Importantly, no hypo-intense spots were observed in areas more distant to the 
lesion site at this very early time point post-injury. However, at 2 weeks post-injury, hypo-
intense signals had now developed within these regions and were clearly visible along the 
caudal axis (Fig. 5B). By 35 days post-injury, hypo-intense areas on MR images could be 
detected at even greater distances away from the original site of impact (Fig. 5C), indicating 
that they are a feature of secondary pathology following SCI and emerge over time. Distant 
hypo-intense areas within MR images appeared to be mostly located within or near the dorsal 
column area. Development of a cystic cavity, which occurred between day 14 and day 35, 
became apparent as bright white, hyper-intense region at the lesion epicenter (Fig. 5C, D). 
High-resolution, post-mortem imaging of the same specimen at 35 days post-injury 
confirmed the existence of distant hypo-intense areas within the spinal cord as well as the 
presence of a cystic cavity at the original impact site (Fig. 5D).  
4. Discussion: 
 
High-resolution MRI is increasingly finding its way into murine models of neurological 
disease, including SCI. MRI has already been used as a tool to measure lesion volume (Nishi 
et al., 2007), white matter sparing and degeneration through diffusion-weighted imaging 
(Kozlowski et al., 2008; Ellingson et al., 2008; Ellingson et al., 2010) and inflammatory 
changes (Ahrens et al., 2011). Our data demonstrate that conventional MRI can still reveal 
subtle pathological features as a result of SCI in and around the lesion site as well as further 
proximal and distal to the site of impact, which may have otherwise gone unnoticed in routine 
histological examination. Specifically, we found in both live mice and post-mortem tissue 
samples that both lesion core and more distant regions contained dark hypo-intense areas in 
gradient echo T2* weighted MR images as a result of high iron content, except for one 
relatively rare occasion in which cyst formation occurred at the impact site (Fig 5C and D).  
Similar hypo-intense signals at the primary injury site have been previously reported upon in 
spinal cord-injured rodents (e.g. Gonzalez-Lara et al., 2009; Qian et al., 2010; Gonzalez-Lara 
et al., 2011) and humans (Wang et al., 2011), but not distal or proximal to the primary injury 
site as observed here.  
 
The acute presence of iron at the lesion epicentre is most likely explained by the initial 
microhaemorrhaging that occurs as a result of blood-spinal cord barrier disruption following 
traumatic contusive injury (Bilgen and Rumboldt, 2008). As iron gets recycled in the CNS, it 
is usually stored within a complex known as hemosiderin. Iron accumulation and 
hemosiderin formation as part of normal SCI pathology is an occurring feature in both 
rodents (Liu et al., 2004; Rathore et al., 2008; Gonzalez-Lara et al., 2011) and humans 
(Koszyka et al., 2002). The ability to non-invasively detect and monitor iron content in the 
CNS may have important implications as previous studies have shown that the formation and 
accumulation of hemosiderin can cause neuronal damage (Heye et al., 1994). In addition, 
removal of accumulated iron from the injured spinal cord with iron chelators reportedly 
improves the functional outcome through mechanisms that could involve reduced 
inflammation (Paterniti et al., 2010) and/or axonal regeneration (for review, see Brazda and 
Müller, 2009). As we were able to show that hypo-intense signals as a result of iron presence 
within the tissue could be easily detected without the use of any contrast enhancing agents, 
high-resolution MR imaging in live animals may provide an important advance by being able 
to monitor the efficacy of iron chelator treatment and lesion site development in pre-clinical 
and clinical studies. 
 
The combination of non-destructive high-resolution MR imaging with subsequent 
histological analysis of the same sample allowed us to further examine the nature of any 
abnormal features that were observed. While the hypo-intense signals at the lesion epicentre 
nicely correlated with the more diffuse pattern of Prussian Blue staining within the tissue of 
the neural scar, iron accumulation in more distant regions was found to be mostly 
intracellular. Accumulation of intracellular iron in the injured spinal cord has been reported 
previously in both microglia/macrophages and oligodendrocytes through histological means 
(Rathore et al., 2008; Schonberg and McTigue, 2009). We confirmed the presence of 
intracellular iron in activated microglia/macrophages as well as oligodendrocytes and provide 
the first evidence that such intracellular iron stores can be detected with relative ease through 
high-resolution MRI in post-mortem tissue samples as well as live animals. Interestingly, 
however, the majority of more distant hypo-intense MR features appeared to arise from high 
levels of intracellular iron in GFAP+ astrocytes. These cells displayed a reactive or 
hypertrophic appearance and were mostly located within the white matter of the dorsal 
funiculus. Little is known about the role of astrocytes in iron metabolism following SCI but 
abnormal iron accumulation in astrocytes was previously reported in a rat model of 
demyelinating disease (Izawa et al., 2010). Although beyond the scope of the present study, it 
is tempting to speculate that such high levels of intracellular iron may be indicative of 
oxidative stress and an indicator of astrogliosis, particularly in those areas undergoing 
prominent Wallerian degeneration. It would be of interest to further investigate this in future 
studies, perhaps with a more severe injury that also engages the lateral funiculi.  
 
Finally, supramagnetic iron particles are increasingly being used for labelling and vivo 
tracking of cell transplants through MRI technology, and numerous studies have already 
applied these in context of the spinal cord (e.g. Dunning et al., 2004; Dunning et al., 2006; 
Geffner et al., 2008; Hu et al., 2009; Gonzales-Laura et al., 2009; Gonzales-Laura et al., 
2011). The present study indicates that, although the loss of MR signal (hypo-intensity) with 
supramagnetic particles is usually far greater than that observed as a result of endogenous 
iron stores, abnormal iron accumulation as a result of pathology should be appropriately 
controlled for, particularly when using ultra-high field MR systems and/or subsequent 
histological means to identify transplanted cells. 
 
In conclusion, we have demonstrated that high-resolution MRI provides a useful tool to 
assess general SCI-related pathology and for monitoring lesion site development. We further 
show that the 16.4T small animal MR system provides enough power to visualize 
intracellular iron accumulation within populations of astrocytes, microglia/macrophages and 
oligodendrocytes in the injured mouse spinal cord.  
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Figures: 
 
Figure 1. Post-mortem MR images of injured mouse spinal cord at 35 days post-SCI. Note 
that a shorter TE better illustrates structure within the hypo-intense core of the lesion 
(arrowheads, A vs. B). A longer TE did increase the contrast between grey and white matter 
regions, however, this came at the cost of diminished contrast between more distant hypo-
intense features of interest and spinal cord white matter (arrows, A vs. B). Also note that a 
longer TE causes an increase in susceptibility artefacts around the bone, loss of trabecular 
bone definition and defined edges of the bone.  
 
 
 
 Figure 2. Post-mortem MR images of mouse spinal cord at (A) day 7 and (C) day 28 post- 
SCI. In the absence of cyst formation, the central core of the lesion appeared as a dark hypo-
intense area. Additional loss of signal was observed spreading for at least several millimeters 
through the dorsal funiculi proximal and distal to site of impact (arrows in A and C), 
particularly in those areas undergoing substantial Wallerian degeneration. (B) Histological 
examination revealed these hypo-intense areas to be high in iron content as determined by 
Prussian blue staining. Inset shows a representative example of iron staining in a coronal 
section through the lesion epicenter. (D) No atypical MR signal was observed in SHAM 
operated mice. Abnormal levels of intracellular iron (blue) were observed (E) proximal and 
(F) distal to the lesion site, particularly within the dorsal column area. (G) Quantitative image 
analysis confirmed the presence of distant, abnormal iron levels within injured spinal cord at 
all time points (p<0.05).  
 
 Figure 3. (A) Cross-sectional ex vivo MR image showing hypo-intense regions at the spinal 
cord lesion epicenter at 28 days post-injury. (B) Histological section taken from 
approximately the same area as shown in A, showing GFP-stained Cx3cr1gfp/+ macrophages 
(MØ) and iron. (C-D) Higher power pictures of boxed areas shown in B. Note that Prussian 
Blue stain at the lesion epicenter appears mostly diffuse and acellular (C). Only occasional 
co-localization of iron within GFP+ macrophages was observed (C, arrow). (E) Adjacent 
section of B, showing the equivalent of the boxed area ´D´. Note the high incidence of co-
localization between Prussian Blue stain and GFAP+ astrocytes (blue + brown => dark green 
/ black).  
 
 Figure 4. Additional, high-power photomicrographs showing (A, D) Prussian Blue stain in 
relation to (B) GFAP+ astrocytes and (E) Iba1+ macrophages/microglia in white matter distal 
to the lesion site at 7 days post-injury. Note that intracellular iron deposits can be observed in 
both cell types at this time point (arrows in C and F; blue + red  => dark purple / black). (G-
I) Additional staining for CC-1, a marker for both astrocytes and oligodendrocytes, revealed 
intracellular iron accumulation in cells reminiscent of both astrocytes (solid arrowhead) and 
oligodendrocytes (open arrowhead).  
 
 
 
 
  
 
 
 
 
Figure 5. In vivo MR images showing lesion site development and SCI-associated pathology. 
Iron deposits were detectable in both gradient echo (A) FLASH and (B,C) spin echo RARE 
images . Note that (A) the hypo-intense signal is restricted to the impact site only at 4 hours 
after injury. (B-C) Progressive loss of signal distal to the lesion site, particularly within the 
dorsal funiculis, became apparent at day 7 (not shown), 14 and 35 after injury (compare also 
coronal insets in A and C). Also note the development of a cystic cavity between day 14 and 
day 35 (asterisk). (D) Post-mortem ex vivo MR imaging at higher resolution confirmed the 
presence of hypo-intense regions distal to the injury site (arrow).  
 
 
